These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9203848)

  • 1. Pharmacokinetic considerations in the development of oligomers as radiopharmaceuticals.
    Hnatowich DJ
    Q J Nucl Med; 1997 Jun; 41(2):91-100. PubMed ID: 9203848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA).
    Mardirossian G; Lei K; Rusckowski M; Chang F; Qu T; Egholm M; Hnatowich DJ
    J Nucl Med; 1997 Jun; 38(6):907-13. PubMed ID: 9189140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 99mTc-labeled oligonucleotides.
    Hnatowich DJ
    Q J Nucl Med; 1996 Sep; 40(3):202-8. PubMed ID: 8961799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of chemical structure of DNA and other oligomer radiopharmaceuticals on tumor delivery.
    Hnatowic DJ; Nakamura K
    Curr Opin Mol Ther; 2006 Apr; 8(2):136-43. PubMed ID: 16610766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell culture and xenograft-bearing animal studies of radiolabeled antisense DNA carrier nanoparticles with streptavidin as a linker.
    Nakamura K; Wang Y; Liu X; Kubo A; Hnatowich DJ
    J Nucl Med; 2007 Nov; 48(11):1845-52. PubMed ID: 17978353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications.
    Mang'era KO; Liu G; Yi W; Zhang Y; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med; 2001 Nov; 28(11):1682-9. PubMed ID: 11702111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length.
    He J; Liu G; Zhang S; Vanderheyden JL; Liu N; Liu C; Zhang Y; Gupta S; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2003; 14(5):1018-23. PubMed ID: 13129406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense and nuclear medicine.
    Hnatowich DJ
    J Nucl Med; 1999 Apr; 40(4):693-703. PubMed ID: 10210231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular distribution and metabolism studies of the potential myocardial imaging agent [99mTc(N)(DBODC)(PNP5)]+.
    Bolzati C; Cavazza-Ceccato M; Agostini S; Tokunaga S; Casara D; Bandoli G
    J Nucl Med; 2008 Aug; 49(8):1336-44. PubMed ID: 18632814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues.
    Sazani P; Gemignani F; Kang SH; Maier MA; Manoharan M; Persmark M; Bortner D; Kole R
    Nat Biotechnol; 2002 Dec; 20(12):1228-33. PubMed ID: 12426578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between single-stranded DNA binding protein and oligonucleotide analogs with different backbone chemistries.
    Cheng X; DeLong RK; Wickstrom E; Kligshteyn M; Demirdji SH; Caruthers MH; Juliano RL
    J Mol Recognit; 1997; 10(2):101-7. PubMed ID: 9376128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
    Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
    J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNase H1 can catalyze RNA/DNA hybrid formation and cleavage with stable hairpin or duplex DNA oligomers.
    Li J; Wartell RM
    Biochemistry; 1998 Apr; 37(15):5154-61. PubMed ID: 9548746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense treatments for biothreat agents.
    Warfield KL; Panchal RG; Aman MJ; Bavari S
    Curr Opin Mol Ther; 2006 Apr; 8(2):93-103. PubMed ID: 16610760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine tuning of electrostatics around the internucleotidic phosphate through incorporation of modified 2',4'-carbocyclic-LNAs and -ENAs leads to significant modulation of antisense properties.
    Zhou C; Liu Y; Andaloussi M; Badgujar N; Plashkevych O; Chattopadhyaya J
    J Org Chem; 2009 Jan; 74(1):118-34. PubMed ID: 19055352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of antisense tumor targeting in mice.
    Nakamura K; Fan C; Liu G; Gupta S; He J; Dou S; Kubo A; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2004; 15(6):1475-80. PubMed ID: 15546217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release profiles and morphological characterization by atomic force microscopy and photon correlation spectroscopy of 99mTechnetium-fluconazole nanocapsules.
    de Assis DN; Mosqueira VC; Vilela JM; Andrade MS; Cardoso VN
    Int J Pharm; 2008 Feb; 349(1-2):152-60. PubMed ID: 17869460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
    Zhang YR; Zhang YX; Cao W; Lan XL
    J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.